Doctors in Lithuania remove nails and screws from man's stomach
Doctors in Lithuania remove nails and screws from man's stomach
Doctors in Lithuania have removed more than two pounds of nails and screws from a man who started swallowing metallic objects after giving up alcohol.
The man, who was not identified for reasons of patient confidentiality, was admitted to hospital in the Baltic port city of Klaipeda with severe abdominal pain.
An X-ray of his stomach showed up pieces of metal - some measuring up to four inches (10 centimetres), doctors said.
© Provided by Daily Mail MailOnline logo
'During the three-hour operation with X-ray control, all foreign bodies, even the smallest ones, in the patient's stomach were removed,' said surgeon Sarunas Dailidenas.
The hospital provided local media with a photograph of a surgical tray heaped with nails and screws.
'We've never seen anything like it,' Algirdas Slepavicius, head surgeon at Klaipeda Hospital told local media.
The doctor said that the man had begun swallowing the metal objects over the last month after he had stopped drinking.
The patient was in a stable condition following the operation, he added.
Reference: Chris Jewers For Mailonline and Afp
New Covid-19 pill in Germany exceeds all expectations
New Covid-19 pill in Germany exceeds all expectations
A new experimental Covid-19 pill reduced stays in hospital and deaths by half, according to German multinational science and technology company Merck.
In fact, an independent group of medical experts that monitored the trial recommended stopping it early because the interim results were so strong, beating all expectations.
The company said today it would soon ask health officials around the world to authorise its use.
If cleared, Merck’s drug would be the first pill shown to treat Covid-19, a potentially major advance in efforts to fight the pandemic.
Merck and its partner Ridgeback Biotherapeutics said early results showed patients who received the drug, called molnupiravir, within five days of Covid-19 symptoms had about half the rate of stays in hospital and death as patients who received a dummy pill.Human trial
The study tracked 775 adults with mild-to-moderate Covid-19 who were considered higher risk for severe disease due to health problems such as obesity, diabetes or heart disease.
Among patients taking molnupiravir, 7.3 per cent were either admitted to hospital or died at the end of 30 days, compared with 14.1 per cent of those getting the dummy pill.
There were no deaths in the drug group after that time period compared with eight deaths in the placebo group, according to Merck.
The results were released by the company and have not been peer reviewed. Merck said it plans to present them at a future medical meeting.
Interim results so strong
An independent group of medical experts monitoring the trial recommended stopping it early because the interim results were so strong.
“It exceeded what I thought the drug might be able to do in this clinical trial,” said Dr Dean Li, vice president of Merck research.
When you see a 50 per cent reduction in hospitalization or death that’s a substantial clinical impact.
Side effects were reported by both groups in the Merck trial, but they were slightly more common among the group that received a dummy pill. The company did not specify the problems.
Earlier study results showed the drug did not benefit patients who were already in hospital with severe disease.
Health experts including the US infectious disease expert Dr Anthony Fauci have long called for a convenient pill that patients could take when Covid-19 symptoms first appear. Such medications are seen as key to controlling future waves of infection and reducing the impact of the pandemic.
Merck’s pill works by interfering with an enzyme the coronavirus uses to copy its genetic code and reproduce itself. It has shown similar activity against other viruses.
Several other companies, including Pfizer and Roche, are studying similar drugs that could report results in the coming weeks and months.Germany company says experimental pill cuts worst effects of Covid-19.
How MDMA and magic mushrooms could be used to treat mental illness
How MDMA and magic mushrooms could be used to treat mental illness
MDMA and magic mushrooms may help treat mental illness, Australia's medicines regulator says ahead of its final decision on whether to recognise the drugs.
The Therapeutic Goods Administration looked at studies on PTSD, treatment-resistant depression, obsessive compulsive disorder, social anxiety in adults with autism, and anxiety or depression in the context of life-threatening disease.
'We conclude that MDMA and psilocybin (the active ingredient in magic mushrooms) may show promise in highly selected populations but only where these medicines are administered in closely clinically supervised settings and with intensive professional support,' the TGA said on Thursday.
It examined studies with MDMA that found statistically significant improvements in adults who had autism and social anxiety.
Results for people who had anxiety in the context of life-threatening disease were not significant given low participant numbers.
Studies seeing whether psilocybin was effective in treating OCD symptoms found no significant effect, possibly because of low numbers and a high response to the placebo.
For people with depression or anxiety, psilocybin was as effective as the antidepressant escitalopram.
In February, the TGA handed down an interim decision against recognising the drugs to treat mental illness.
It deferred a final decision pending the review on the drugs' therapeutic value, risks and benefits.
The report will be considered by the Advisory Committee of Medicines Scheduling on November 3 ahead of a final decision due in early December.
Reference: Georgie Moore For Australian Associated Press
Reduce paracetamol use, experts tell pregnant women
Reduce paracetamol use, experts tell pregnant women
Pregnant women should reduce their use of paracetamol and warnings should be added to packaging, an international coalition of experts said today.
They said there was growing evidence paracetamol might affect a baby’s development in the womb and increase the risk of ADHD (attention deficit hyperactivity disorder) and autism.
They added it should only be taken at the “lowest effective dose for the shortest possible time” and pregnant women should avoid “indiscriminate” use.
Current NHS advice is that pregnant and breastfeeding women can take paracetamol safely. Both the US and European medicines regulators say the drug is of minimal risk when taken correctly during pregnancy.
More than half of pregnant women worldwide are thought to take it to relieve fever and pain, as alternatives such as ibuprofen are not recommended in later stages of pregnancy.
Today, more than 90 experts, including from the US, Scotland, Denmark, Sweden and France, issued a “consensus statement” calling for precautions to be taken in the use of paracetamol in pregnancy after reviewing 25 years of research on the subject.
They also said there should be targeted research into the apparent increased risk of “neurodevelopmental, reproductive and urogenital” disorders.
They said there were “disturbing increases” in the number of children with cognitive, learning and/or behavioural problems.
© PA virus-.jpg
Some research also suggested an increased risk of undescended testicles in boys and early puberty in girls.
However, it is also known an untreated fever in a pregnant woman carries a slight risk of neural and heart disorders, and paracetamol helps reduce that.
Andrew Shennan, professor of obstetrics, King’s College London, who was not involved in the research, said it was a “balanced view of the potential risk/benefit of paracetamol in pregnancy”.
Professor Shennan said: “They point out that treating pain and fever could reduce pregnancy risks, and alternatives to paracetamol have got evidence of harm. The evidence that paracetamol is harmful is not strong but observations in humans regarding possible developmental issues are supported by animal studies.
“It is always important to take medication in pregnancy with specialist advice. A good principle is to only use medications with a proven track record of both efficacy and safety. Paracetamol is one of those drugs that can be safely used.
“The baby is fully formed by 10 weeks of pregnancy and it is unlikely a drug will cause significant harm in fetal development after this point.
“Prudent surveillance and more research should continue but paracetamol can be used to treat pain and fevers in pregnancy.”
Dr Sarah Stock, Reader and Consultant Maternal and Fetal Medicine, University of Edinburgh Usher Institute, said: “This paper doesn’t change recommendations on paracetamol use in pregnancy.
“The team have done a good job of bringing together existing evidence, but unfortunately, much of that evidence is not robust enough to draw any conclusions that paracetamol use in pregnancy, especially occasional use, causes developmental problems in humans.
“Paracetamol is effective at reducing pain and fever, and so continues to be an important medicine that pregnant people should use if needed.
“Of course, pregnant or not, no-one should take a medication unnecessarily, for longer than necessary or at a higher dose than needed.
“There is no new data in this publication — it is a summary of previous studies. The authors rightly lobby for more good quality research, as based on current evidence from previously-published studies it is impossible to disentangle whether it is conditions that cause people to take paracetamol at high doses for long periods of time, or paracetamol itself, that might have a link to developmental problems.”
Reference: Evening Standard: Ross Lydall
Articles - Most Read
- Home
- LIVER DIS-EASE AND GALL BLADDER DIS-EASE
- Contacts
- African Wholistics - Medicines, Machines and Ignorance
- African Wholistics -The Overlooked Revolution
- African Holistics - Seduced by Ignorance and Research
- The Children of the Sun-3
- Kidney Stones-African Holistic Health
- The Serpent and the RainBow-The Jaguar - 2
- PART ONE: DIS-EASE TREATMENT AND HEALTH-3
- 'Tortured' and shackled pupils freed from Nigerian Islamic school
- King Leopold's Ghost - Introduction
- PART ONE: DIS-EASE TREATMENT AND HEALTH-4
- PART ONE: DIS-EASE TREATMENT AND HEALTH-2
- PART ONE: DIS-EASE TREATMENT AND HEALTH-5
- African Wholistics - Medicine
- Menopause
- The Black Pharaohs Nubian Pharaohs of Ancient Egypt
- The Mystery System
- PART ONE: DIS-EASE TREATMENT AND HEALTH-6
Who's On Line?
We have 96 guests and no members online
Ad Agency Remote
Articles - Latest
- The Male G Spot Is Real—and It's the Secret to an Unbelievable Orgasm
- Herbs for Parasitic Infections
- Vaginal Care - From Pubes to Lubes: 8 Ways to Keep Your Vagina Happy
- 5 Negative Side Effects Of Anal Sex
- Your Herbs and Spices Might Contain Arsenic, Cadmium, and Lead
- Struggling COVID-19 Vaccines From AstraZeneca, BioNTech/Pfizer, Moderna Cut Incidence Of Arterial Thromboses That Cause Heart Attacks, Strokes, British Study Shows
- Cartilage comfort - Natural Solutions
- Stop Overthinking Now: 18 Ways to Control Your Mind Again
- Groundbreaking method profiles gene activity in the living brain
- Top 5 health benefits of quinoa
- Chromolaena odorata - Jackanna Bush
- Quickly Drain You Lymph System Using Theses Simple Techniques to Boost Immunity and Remove Toxins
- Doctors from Nigeria 'facing exploitation' in UK
- Amaranth, callaloo, bayam, chauli
- 9 Impressive Benefits of Horsetail
- Collagen The Age-Defying Secret Of The Stars + Popular Products in 2025
- Sarcopenia With Aging
- How to Travel as a Senior (20 Simple Tips)
- Everything you need to know about mangosteen